Literature DB >> 33535451

Indicator Compounds Representative of Contaminants of Emerging Concern (CECs) Found in the Water Cycle in the United States.

Shuangyi Zhang1, Stephen Gitungo2, John E Dyksen3, Robert F Raczko3, Lisa Axe4.   

Abstract

The presence of contaminants of emerging concern (CECs) in the aquatic environment has recently become a global issue. The very large number of CECs reported in the literature makes it difficult to interpret potential risks as well as the removal efficiencies, especially for the more recalcitrant compounds. As such, there is a need for indicator compounds that are representative of CECs detected in systems worldwide. In an effort to develop such a list, five criteria were used to address the potential for applying indicator compounds; these criteria include usage, occurrence, resistance to treatment, persistence, and physicochemical properties that shed light on the potential degradability of a class of compounds. Additional constraints applied included the feasibility of procuring and analyzing compounds. In total, 22 CECs belonging to 13 groups were selected as indicator compounds. These compounds include acetaminophen and ibuprofen (analgesic); erythromycin, sulfamethoxazole, and trimethoprim (antibiotics); diazepam and fluoxetine (antidepressants); carbamazepine (antiepileptic); atenolol and propranolol (β-blockers); gemfibrozil (blood lipid regulator); tris(2-chloroethyl)phosphate (TCEP) (fire retardant); cotinine (nicotine metabolite); atrazine, metolachlor, and N,N-diethyl-meta-toluamide (DEET) (pesticides); 17β-estradiol and cholesterol (steroids); caffeine (psychomotor stimulant); perfluorooctane sulfonate (PFOS) and perfluorooctanoic acid (PFOA) (surfactants); and iopromide (X-ray contrast agent). These thirteen groups of compounds represent CECs with the greatest resistance to treatment processes, most persistent in surface waters, and detected with significant frequency throughout the water cycle. Among the important implications of using indicator compounds are the ability to better understand the efficacy of treatment processes as well as the transport and fate of these compounds in the environment.

Entities:  

Keywords:  contaminants of emerging concern; indicator compounds; occurrence and usage; physicochemical properties; water and wastewater treatment; water cycle

Year:  2021        PMID: 33535451      PMCID: PMC7908579          DOI: 10.3390/ijerph18031288

Source DB:  PubMed          Journal:  Int J Environ Res Public Health        ISSN: 1660-4601            Impact factor:   3.390


  149 in total

1.  Exposure of juvenile roach (Rutilus rutilus) to treated sewage effluent induces dose-dependent and persistent disruption in gonadal duct development.

Authors:  T P Rodgers-Gray; S Jobling; C Kelly; S Morris; G Brighty; M J Waldock; J P Sumpter; C R Tyler
Journal:  Environ Sci Technol       Date:  2001-02-01       Impact factor: 9.028

2.  Evaluating the extent of pharmaceuticals in surface waters of the United States using a National-scale Rivers and Streams Assessment survey.

Authors:  Angela L Batt; Thomas M Kincaid; Mitchell S Kostich; James M Lazorchak; Anthony R Olsen
Journal:  Environ Toxicol Chem       Date:  2015-11-12       Impact factor: 3.742

3.  Widespread occurrence of neuro-active pharmaceuticals and metabolites in 24 Minnesota rivers and wastewaters.

Authors:  Jeffrey H Writer; Imma Ferrer; Larry B Barber; E Michael Thurman
Journal:  Sci Total Environ       Date:  2013-06-07       Impact factor: 7.963

4.  Acute exposure to an environmentally relevant concentration of diclofenac elicits oxidative stress in the culturally important galaxiid fish Galaxias maculatus.

Authors:  Nicole K McRae; Chris N Glover; S Rebekah Burket; Bryan W Brooks; Sally Gaw
Journal:  Environ Toxicol Chem       Date:  2017-12-04       Impact factor: 3.742

5.  Emerging wastewater contaminant metformin causes intersex and reduced fecundity in fish.

Authors:  Nicholas J Niemuth; Rebecca D Klaper
Journal:  Chemosphere       Date:  2015-04-18       Impact factor: 7.086

6.  Occurrence and reductions of pharmaceuticals and personal care products and estrogens by municipal wastewater treatment plants in Ontario, Canada.

Authors:  Lori Lishman; Shirley Anne Smyth; Kurtis Sarafin; Sonya Kleywegt; John Toito; Thomas Peart; Bill Lee; Mark Servos; Michel Beland; Peter Seto
Journal:  Sci Total Environ       Date:  2006-05-12       Impact factor: 7.963

7.  Occurrence of perfluoroalkyl carboxylates and sulfonates in drinking water utilities and related waters from the United States.

Authors:  Oscar Quiñones; Shane A Snyder
Journal:  Environ Sci Technol       Date:  2009-12-15       Impact factor: 9.028

8.  Conventional drinking water treatment and direct biofiltration for the removal of pharmaceuticals and artificial sweeteners: A pilot-scale approach.

Authors:  Michael J McKie; Susan A Andrews; Robert C Andrews
Journal:  Sci Total Environ       Date:  2015-12-02       Impact factor: 7.963

9.  Chronic and low exposure to a pharmaceutical cocktail induces mitochondrial dysfunction in liver and hyperglycemia: Differential responses between lean and obese mice.

Authors:  Nelly Buron; Mathieu Porceddu; Célestin Roussel; Karima Begriche; Viviane Trak-Smayra; Thomas Gicquel; Bernard Fromenty; Annie Borgne-Sanchez
Journal:  Environ Toxicol       Date:  2016-08-08       Impact factor: 4.119

Review 10.  Pharmaceuticals and personal care products in the environment: agents of subtle change?

Authors:  C G Daughton; T A Ternes
Journal:  Environ Health Perspect       Date:  1999-12       Impact factor: 9.031

View more
  1 in total

1.  Spatial and temporal variability of contaminants of emerging concern in a drinking water source.

Authors:  Rama Pulicharla; Francois Proulx; Sonja Behmel; Jean-B Sérodes; Manuel J Rodriguez
Journal:  RSC Adv       Date:  2022-07-21       Impact factor: 4.036

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.